STATE STREET CORP - PROTAGENIC THERAPEUTICS INC ownership

PROTAGENIC THERAPEUTICS INC's ticker is PTIX and the CUSIP is 74365N103. A total of 1 filers reported holding PROTAGENIC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of PROTAGENIC THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$46,186
+44.3%
110,492
+100.0%
0.00%
Q3 2022$32,000
-20.0%
55,2460.0%0.00%
Q2 2022$40,000
-11.1%
55,2460.0%0.00%
Q1 2022$45,000
-40.0%
55,246
+1.6%
0.00%
Q4 2021$75,000
-26.5%
54,4000.0%0.00%
Q3 2021$102,000
-64.2%
54,400
-44.9%
0.00%
Q2 2021$285,00098,8000.00%
Other shareholders
PROTAGENIC THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
FNY Investment Advisers, LLC 75,000$310.04%
Concorde Asset Management, LLC 16,718$6,6870.01%
Virtu Financial LLC 10,110$40.00%
Warberg Asset Management LLC 20,000$8,0000.00%
CWM, LLC 3$00.00%
VANGUARD GROUP INC 236,309$94,5230.00%
UBS Group AG 17,153$6,8610.00%
OSAIC HOLDINGS, INC. 11,055$4,0000.00%
BANK OF AMERICA CORP /DE/ 4$20.00%
WELLS FARGO & COMPANY/MN 90$360.00%
View complete list of PROTAGENIC THERAPEUTICS INC shareholders